www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

KL1333

Catalogue number:
HY-128895-1mL
Supplier:
Size:
1 ml _$$_
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£602.00 Shipping is calculated in checkout
This product is for research use only and is not for human consumption or therapeutic use.
CAS Number:

1800405-30-4

Purity:

98

Molecular Formula:

C14H12N2O2

Molecular Weight:

240.26

Product Description:

KL1333, a derivative of β-lapachone, is an orally available NAD+ modulator. KL1333 reacts with NAD(P)H:quinone oxidoreductase 1 (NQO1) as a substrate, resulting in increases in intracellular NAD+ levels via NADH oxidation. KL1333 improves energy metabolism and mitochondrial dysfunction in MELAS fibroblasts. KL1333 protects against Cisplatin-induced ototoxicity in mouse cochlear cultures[1][2].

Storage Temperature:

-20°C, 3 years; 4°C, 2 years (Powder)

NQO1 activator 1
NQO1 activator 1
Details Cat number & supplier Size Price
PXS-5153A (monohydrochloride) HY-114286A-1mL · MedChem Express
HY-114286A-1mL
MedChem Express
1 ml £421.00
1 ml
view
AMG-548 (dihydrochloride) HY-108642B-1mL · MedChem Express
HY-108642B-1mL
MedChem Express
1 ml £394.00
1 ml
view
FAAH-IN-2 HY-79511-500mg · MedChem Express
HY-79511-500mg
MedChem Express
500 mg £107.00
500 mg
view
Ganetespib HY-15205-50mg · MedChem Express
HY-15205-50mg
MedChem Express
50 mg £261.00
50 mg
view
SEC inhibitor KL-2 HY-123972-1mg · MedChem Express
HY-123972-1mg
MedChem Express
1 mg £131.00
1 mg
view
Mal-amido-PEG8-C2-acid HY-101159-50mg · MedChem Express
HY-101159-50mg
MedChem Express
50 mg £199.00
50 mg
view
NS13001 HY-102070-10mg · MedChem Express
HY-102070-10mg
MedChem Express
10 mg £367.00
10 mg
view
C3a (70-77) (TFA) HY-P1505A-5mg · MedChem Express
HY-P1505A-5mg
MedChem Express
5 mg £237.00
5 mg
view
Isorhamnetin-3-O-glucoside HY-N0777-5mg · MedChem Express
HY-N0777-5mg
MedChem Express
5 mg £373.00
5 mg
view
Aranidipine HY-U00212-10mg · MedChem Express
HY-U00212-10mg
MedChem Express
10 mg £131.00
10 mg
view